Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks

[1]  R. Khalilov,et al.  Investigation of Antimicrobial and Cytotoxic Properties and Specification of Silver Nanoparticles (AgNPs) Derived From Cicer arietinum L. Green Leaf Extract , 2022, Frontiers in Bioengineering and Biotechnology.

[2]  M. Ángel Martínez.  Efficacy of repurposed antiviral drugs: lessons from COVID-19 , 2022, Drug Discovery Today.

[3]  E. Zaslavsky,et al.  Advances in the computational landscape for repurposed drugs against COVID-19 , 2021, Drug Discovery Today.

[4]  B. Villoutreix,et al.  Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises , 2021, Computational and Structural Biotechnology Journal.

[5]  A. Madni,et al.  Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic , 2021, European Journal of Pharmacology.

[6]  T. Sauter,et al.  Topological network measures for drug repositioning , 2020, Briefings Bioinform..

[7]  Serena Dotolo,et al.  A review on drug repurposing applicable to COVID-19 , 2020, Briefings Bioinform..

[8]  Yanwen Chong,et al.  Graph-based semi-supervised learning: A review , 2020, Neurocomputing.

[9]  F. Tacke,et al.  Dexamethasone nanomedicines for COVID-19 , 2020, Nature Nanotechnology.

[10]  L. Rudnicka,et al.  The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections , 2020, Biology.

[11]  Jon G. Rokne,et al.  A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions , 2020, Journal of Cheminformatics.

[12]  Heidi Ledford.  Coronavirus breakthrough: dexamethasone is first drug shown to save lives , 2020, Nature.

[13]  L. Steinman,et al.  Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’1 attack , 2020, Journal of the Neurological Sciences.

[14]  The COVID-19 Host Genetics Initiative.  The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic , 2020, European Journal of Human Genetics.

[15]  M. Hall,et al.  Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19 , 2020, ACS central science.

[16]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[17]  P. Middleton,et al.  Ongoing Clinical Trials for the Management of the COVID-19 Pandemic , 2020, Trends in Pharmacological Sciences.

[18]  Bolin Wang,et al.  Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis , 2020, Aging.

[19]  F. Cheng,et al.  Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 , 2020, Cell Discovery.

[20]  Bo Li,et al.  Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China , 2020, Clinical Research in Cardiology.

[21]  Wei Wang,et al.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.

[22]  Wankyu Kim,et al.  In silico drug repositioning: from large-scale transcriptome data to therapeutics , 2019, Archives of Pharmacal Research.

[23]  Hyunjung Shin,et al.  Drug repurposing with network reinforcement , 2019, BMC Bioinformatics.

[24]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[25]  Hyunjung Shin,et al.  Disease gene identification based on generic and disease-specific genome networks , 2018, Bioinform..

[26]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2019 , 2018, Nucleic Acids Res..

[27]  Hyunjung Shin,et al.  An inference method from multi-layered structure of biomedical data , 2017, BMC Medical Informatics and Decision Making.

[28]  Hyunjung Shin,et al.  CLASH: Complementary Linkage with Anchoring and Scoring for Heterogeneous biomolecular and clinical data , 2016, BMC Medical Informatics and Decision Making.

[29]  Pasquale De Meo,et al.  Generalized Louvain method for community detection in large networks , 2011, 2011 11th International Conference on Intelligent Systems Design and Applications.

[30]  Fei Wang,et al.  Graph-based semi-supervised learning , 2009, Artificial Life and Robotics.

[31]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[32]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[33]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..